← Back to Search

Social Value Training for Autism Spectrum Disorder(SVT Trial)

Yale University School of Medicine, New Haven, CT
Targeting 2 different conditionsSocial Value Learning TrainingN/ARecruitingLed by Katarzyna Chawarska, PhDResearch Sponsored by Yale University

SVT Trial Summary

This trial is testing a new method of training called Social Value Training (SVT) to see if it can help reduce symptoms of ASD in toddlers.

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism

SVT Trial Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
You have an older brother or sister who has autism spectrum disorder (ASD).
You are pregnant with only one baby.

SVT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~average trial duration: for laboratory task: 2 seconds, for real-world task: 1 minute
This trial's timeline: 3 weeks for screening, Varies for treatment, and average trial duration: for laboratory task: 2 seconds, for real-world task: 1 minute for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of looking at faces during the laboratory and real-world tests
Secondary outcome measures
Proportion of looking at the scene during laboratory and real-world tests

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

SVT Trial Design

1Treatment groups
Experimental Treatment
Group I: Social Value LearningExperimental Treatment1 Intervention
For each child, two faces, randomly selected from the pool of four faces, will be assigned the high-value (HV) status and the other two the low-value (LV) status. Value status will be randomized between the faces and children and all four faces will have the same probability of being assigned HV or LV across all participants. A gaze fixation on a HV face will always activate a dynamic display and the face will smile brightly. A gaze fixation on a LV face will always result in no change to its display. Effects of training will be tested one day (efficacy) and one month (maintenance) after training. During each of the follow-up assessments, each child will first undergo the Laboratory Selective Attention (LSA) task to assess if they retained value-face associations from the training sessions, followed by the Real-World Selective Attention (RWSA) task to evaluate generalization.

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,806 Previous Clinical Trials
2,711,633 Total Patients Enrolled
25 Trials studying Autism Spectrum Disorder
2,304 Patients Enrolled for Autism Spectrum Disorder
National Institute of Mental Health (NIMH)NIH
2,718 Previous Clinical Trials
2,446,331 Total Patients Enrolled
79 Trials studying Autism Spectrum Disorder
40,932 Patients Enrolled for Autism Spectrum Disorder
Katarzyna Chawarska, PhDPrincipal InvestigatorSocial and Affective Neuroscience of Autism Program, Yale Child Study Center
1 Previous Clinical Trials
30 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
30 Patients Enrolled for Autism Spectrum Disorder

Media Library

Social Value Learning Training Clinical Trial Eligibility Overview. Trial Name: NCT03556826 — N/A
Autism Spectrum Disorder Research Study Groups: Social Value Learning
Autism Spectrum Disorder Clinical Trial 2023: Social Value Learning Training Highlights & Side Effects. Trial Name: NCT03556826 — N/A
Social Value Learning Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT03556826 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacant slots where volunteers can participate in this clinical trial?

"According to the latest information contained on clinicaltrials.gov, this trial is actively searching for eligible participants; it was initially posted in December 2019 and updated most recently in July 2022."

Answered by AI

Is my profile appropriate to be considered for this clinical study?

"This trial is enrolling 48 infants with autism spectrum disorder between 15 and 21 months of age. To qualify, applicants must have been born within a gestational period of 37-42 weeks; have an older full biological sibling diagnosed with ASD; meet the Autism Diagnostic Observation Schedule-2 (ADOS-2) criteria at 18 months of age, as denoted by a calibrated severity score above 3."

Answered by AI

Is the age criterion for this research limited to those above 85 years old?

"The eligibility requirements for this trial restrict enrollment to infants aged 15-21 months. There are 228 trials currently recruiting minors and 42 that seek the participation of elderly individuals."

Answered by AI

What is the upper limit of participants in this research endeavor?

"Affirmative. Clinicaltrials.gov conveys that this clinical trial, which commenced on December 13th 2019, is currently enrolling participants. There is a need for 48 individuals to go through the study at one particular site."

Answered by AI
~10 spots leftby Dec 2024